Reaction biological sciences, with the support of Sam Al -Tamman, gathered one billion dollars to extend human life

SAM Altman, CEO of Openai, doubles on Retro Biosis, a biotechnology company based in San Francisco, wants people to live for 10 years, which he calls a healthy human age.

Previously available The full seed round of $ 180 million biological sciences. Now, the startup collects the A billion dollar chain that Altman joins, Financial times Reports.

Reactionary biological sciences, which it says plans to launch experiments of drugs targeting diseases such as Alzheimer’s disease, recently Training model With openai to convert regular cells into stem cells.

Joe Betts-Lacroix told FT that he wanted to move quickly by discovering and developing a drug “in the twenties of the last century.”

The startup joins the billionaire billionaire length efforts, including Altos Labs, which Firing With 3 billion dollars in 2022 with the support of Jeff Bezos, biotechnology unit, Backed By both Bezos and Peter Thil.